Table 1. Extracellular volume (ECV), plasma volume (PV) and total tissue water (TTW) measured in the animals treated with either PBS, PTK/ZK, STI571 as well as short and long term combination treatment.
Tumor | Skin | |||||
TTW (mL/g dry weight) | PV (mL/g dry weight) | ECV (mL/g dry weight) | TTW (mL/g dry weight) | PV (mL/g dry weight) | ECV (mL/g dry weight) | |
PBS (n = 10) | 4.756±0.668 | 0.041±0.019 | 1.612±0.451 | 1.944±0.406 | 0.008±0.005 | 1.357±0.430 |
STI571 4d (n = 7) | 5.162±0.208 | 0.047±0.020 | 2.187±0.321 * | 2.804±1.404 | 0.017±0.006§ | 2.053±0.851§ |
PTK/ZK 4d (n = 8) | 4.977±0.538 | 0.052±0.033 | 1.533±0.311 | 2.573±0.744 | 0.018±0.012 | 1.614±0.422 |
PTK/ZK 2d/STI571 4d (n = 7) | 4.658±0.876 | 0.156±0.250 | 1.515±0.481 | 3.122±1.279 | 0.110±0.106 * | 2.399±1.097 * |
PTK/ZK 4d/STI571 4d (n = 6) | 5.187±0.789 | 0.046±0.026 | 2.140±0.587 | 2.348±0.672 | 0.016±0.006 | 1.704±0.527 |
All results are presented as mean and S.E.M. Analysis of statistical significance was evaluated with 1-way ANOVA followed by the post-hoc Dunn's test.
p<0.05 compared to PBS treatment.
p<0.05 compared to PBS treatment when removing the highest outlying data point in PTK/ZK 2d/STI571 4d treatment group.